The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies
Tóm tắt
Từ khóa
Tài liệu tham khảo
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.
Holman RR, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464–76.
Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections. The DIAMOND randomized clinical trial. JAMA. 2017;317:371–8.
Beck RW, Riddlesworth T, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167:365–74.
Lind M, Polonsky W, Hirsch IB, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial JAMA. 2017;317:379–87.
Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia. 2012;55:3155–62.
Campbell F, Murphy N, Stewart C, et al. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Paediatr Diabetes. 2018. https://doi.org/10.1111/pedi.12735 .
Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388:2254–63.
Haak T, Hanaire H, Ajjan R, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8:55–73.
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008–12.
von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495–9.
Gibb FW, Stimson RH, Zammitt NN, et al. Flash glucose monitoring is associated with improved glycaemic control and quality of life in people with type 1 diabetes: a large ‘real-world’ assessment. Diabetologia. 2018;16(S1):S391.
Xatzipsalti M, Mentesidou L, Kourti A, et al. Flash glucose monitoring system improves glycemic control. Pediatr Diabetes. 2017;18(Suppl. 25):78.
Reddy M, Jugnee N, El Laboudi A, et al. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with type 1 diabetes and impaired awareness of hypoglycaemia. Diabetes Med. 2018;35:483–90.
Moreno-Fernandez J, Pazos-Couselo M, González-Rodriguez M, et al. Clinical value of flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion. Endocrinol Diabetes Nutr. 2018;65:556–63.
Helm N, De ML, Forsman S, et al. Flash glucose monitoring improves perception and frequency of glucose monitoring leading to improved glucose control. Pediatr Diabetes. 2016;17:115.
Messaaoui A, Tentoutasse S, Crenier L. Flash glucose monitoring in children–one-year experience. Diabetes. 2016;67(S1):946.
Wijnands A, Gys I, Bevilacqua E, et al. The FreeStyle flash glucose monitoring system has limited effect on the metabolic control of children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2017;18(Suppl. 25):38.
McKnight JA, Gibb FW. Flash glucose monitoring is associated with improved glycaemic control but use is largely limited to more affluent people in a UK diabetes centre. Diabetes Med. 2017;34:732. https://doi.org/10.1111/dme.13315 .
Walton-Betancourth S, Amin R. A clinic-based study of the impact of flash glucose sensing technology on glycaemic control and self-monitoring of blood glucose in children and young people with type 1 diabetes. Pediatr Diabetes. 2017;18(Suppl. 25):47.
Dover AR, Stimson RH, Zammitt NN, Gibb FW. Flash glucose monitoring improves outcomes in a type 1 diabetes clinic. J Diabetes Sci Technol. 2017;11(2):442–3.
Bacon S, O’Dwyer B, Chambers C, et al. The performance and technical usability of a flash glucometer monitoring system. Irish J Med Sci. 2017;186(9):S357.
Dørflinger GH, Østergaard JA, Fisker S, et al. The effect of flash glucose monitoring on glycemic control in patients with type 1 diabetes. Diabetes. 2018;67(S1):942.
Pintus D, Ng SM. FreeStyle Libre Flash glucose monitoring (Flash GM) system improves glycaemic control and patient quality of life measures in children with type 1 diabetes with appropriate provision of Flash GM education and support by healthcare professionals. Pediatr Diabetes. 2017;18(S25):eP004.
Karlsson E. HbA1c after one year of use of flash glucose monitoring in patients with type 1 diabetes. Thesis, University of Orebero, Sweden.
Al Hayek A, Asirvatham RA, Al Dawish M. Evaluation of FreeStyle Libre flash glucose monitoring system on glycemic control, health-related quality of life, and fear of hypoglycemia in patients with type 1 diabetes. Clin Med Insights Endocrinol Diabetes. 2017;10:1–6.
Paris I, Henry C, Pirard F, et al. The new FreeStyle Libre flash glucose monitoring system improves the glycaemic control in a cohort of people with type 1 diabetes followed in real-life conditions over a period of one year. Endocrinol Diabetes Metab. 2018. https://doi.org/10.1002/edm2.23 .
Abdalaziz A, Lan K, Bilous M, et al. Flash glucose monitoring (FGM) in people with type 1 diabetes: single centre-real-world experience. Diabetes Med. 2018;35(S1):168.
Yaron M, Roitman E, Aharon-Hananel G, et al. Intervention of the flash glucose sensing technology on glycemic control and treatment satisfaction in patients with type 2 diabetes treated intensively using insulin: a randomized controlled trial. Diabetes. 2018;67(S1):908.
Weiss J, Cohen N, Zajac JD, et al. Flash glucose monitoring—using technology to improve outcomes for patients with diabetes. Aust J Rural Health. 2018;26:453–4.
Löndahl M, Filipsson K, Lindholm E, et al. Effect of flash glucose monitoring on metabolic control and self-esteem treatment satisfaction in people with T1DM. Diabetes Technol Ther. 2017;19(S1):A-81.
Landau Z, Abiri S, Gruber N, et al. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: aWeSoME study group real-life observational experience. Acta Diabetol. 2018;55:1303–10.
Ish-Shalom M, Wainstein J, Raz I, et al. Improvement in glucose control in difficult-to-control patients with diabetes using a novel flash glucose monitoring device. J Diabetes Sci Technol. 2016;5:1572–83.
Holcombe A, Karunakaran V, Streeting J, et al. Trial of FreeStyle Libre in a local service: impact on diabetes outcomes. Diabetes Med. 2017;34(S1):160.
Tirelli E, Frontino G, Favalli V, et al. Flash glucose monitoring in noncompliant children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2017;19(S1):A-83.
Hey C, Alkharaiji M, Anyanwagu U, et al. Impact of FreeStyle Libre on glycaemic control, frequency of glucose monitoring and treatment satisfaction. Diabetes Med. 2018;35(Supplement 1):195.
Mitchell K, McDougall C. Trial of FreeStyle Libre flash glucose monitoring (FGM) in patients with poorly controlled type 1 diabetes. Diabetes Med. 2018;35(S1):160.
Higgins JPT, Thompson SG, Deeks J, et al. Measuring inconsistency in meta-analysis. BMJ. 2003;327:557–60.
Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted. Stat Med. 2002;21:1559–73.